SCHEMBL17226416

SCHEMBL17226416

Cn1ncc2cnc3[nH]c(I)cc3c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16517899 0.83 CCNK (0.38) —
SCHEMBL1536818 0.75 KIT (0.45) —
SCHEMBL2317117 0.75 IKBKB (0.36) —
SCHEMBL2316874 0.75 KIT (0.42) —
SCHEMBL12389804 0.74 CCNB2 (0.48) —
SCHEMBL2315670 0.72 CCNT1 (0.37) —
SCHEMBL2318685 0.72 KIT (0.44) —
SCHEMBL2316035 0.71 JAK2 (0.44) —
SCHEMBL2318637 0.71 TBK1 (0.40) —
SCHEMBL2319679 0.71 FGFR3 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2299821-B1 TRICYCLIC COMPOUNDS ABBVIE INC (US) 2015-11-04 — — EP disclosed
Send feedback